IMC Chicago
OCUL icon

IMC Chicago’s Ocular Therapeutix OCUL Stock Holding History

IMC Chicago’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.8M Buy
+756,372
New +$7.4M ﹤0.01% 2086
2026
Q1 		– Sell
-97,202
Closed -$926K – 5890
2025
Q4 		$1.18M Buy
+97,202
New +$1.18M ﹤0.01% 2851
2025
Q3 		– Sell
-207,765
Closed -$2.48M – 3797
2025
Q2 		$1.93M Buy
+207,765
New +$1.63M ﹤0.01% 2030

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $135M AUM 15.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Kraematon Investment Advisors
Kraematon Investment Advisors Braintree, Massachusetts $134M AUM 18.69% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return

IMC Chicago's OCUL Position: Q3 2026 in Review

IMC Chicago opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 756,372 shares worth $5.8M. The stake represents ﹤0.01% of the portfolio and ranks #2086 among its holdings. This is a return to the name: IMC Chicago previously reported a position in OCUL as recently as Q4 2025.

IMC Chicago first reported a position in OCUL in Q2 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • IMC Chicago held 756,372 shares of Ocular Therapeutix worth $5.8M as of Q3 2026.
  • Ocular Therapeutix was a new IMC Chicago position in Q3 2026.
  • Ocular Therapeutix made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2086 holding.
  • IMC Chicago first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.